Yeah a “goal” by “end of the year” but obviously he is focusing hard on what they need to do to get there with sales targets. Which is the right way to go with the “what will make us cash flow positive” mindset while setting up a foundation. If they start hitting them along the way it’ll surely be a big sign of the end of year goal.
- Forums
- ASX - By Stock
- DCF valuation $0.08
Yeah a “goal” by “end of the year” but obviously he is focusing...
-
-
- There are more pages in this discussion • 370 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXN (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.001(1.23%) |
Mkt cap ! $15.13M |
Open | High | Low | Value | Volume |
8.2¢ | 8.2¢ | 8.1¢ | $14.66K | 181.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 202038 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 249981 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 202038 | 0.081 |
1 | 174926 | 0.080 |
2 | 63750 | 0.079 |
2 | 219999 | 0.078 |
1 | 62233 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 249981 | 1 |
0.085 | 100811 | 2 |
0.089 | 11245 | 1 |
0.090 | 179000 | 2 |
0.093 | 8500 | 1 |
Last trade - 13.59pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
DXN (ASX) Chart |